BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25194546)

  • 1. Editorial comment.
    Ukimura O
    J Urol; 2014 Dec; 192(6):1648; discussion 1649. PubMed ID: 25194546
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment.
    Phillips J
    J Urol; 2014 Dec; 192(6):1649; discussion 1649. PubMed ID: 25194544
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial comment.
    Schilling D; Stenzl A
    J Urol; 2010 Feb; 183(2):527-8; discussion 528. PubMed ID: 20006885
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel biomarkers and advanced imaging modalities in the early detection of prostate cancer.
    Parsons JK
    J Urol; 2015 Apr; 193(4):1084-5. PubMed ID: 25596362
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment to association of prostate-specific antigen doubling time and cancer in men undergoing repeat prostate biopsy.
    Shimbo M
    Int J Urol; 2012 Aug; 19(8):747-8. PubMed ID: 22651131
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial Comment to Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer.
    Yashi M
    Int J Urol; 2015 Jun; 22(6):561-2. PubMed ID: 25799888
    [No Abstract]   [Full Text] [Related]  

  • 7. State-of-the-art staging in prostate cancer.
    Wilkinson BA; Hamdy FC
    BJU Int; 2001 Mar; 87(5):423-30. PubMed ID: 11298030
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment from Dr Urakami to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Urakami S
    Int J Urol; 2014 Oct; 21(10):990-1. PubMed ID: 24909066
    [No Abstract]   [Full Text] [Related]  

  • 9. Editorial comment from Dr Simonato and Dr Romagnoli to impact of obesity on the predictive accuracy of prostate-specific antigen density and prostate-specific antigen in native Korean men undergoing prostate biopsy.
    Simonato A; Romagnoli A
    Int J Urol; 2014 Oct; 21(10):991. PubMed ID: 24931339
    [No Abstract]   [Full Text] [Related]  

  • 10. Editorial comment. Correlation between serum prostate-specific antigen and cancer volume in prostate glands of different sizes.
    Autorino R; Perdonà S; Di Lorenzo G
    Urology; 2010 Nov; 76(5):1076; author reply 1076-7. PubMed ID: 21056255
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial comment on: decision-making about PSA testing and prostate biopsies: a qualitative study embedded in a primary care randomised trial.
    Finney Rutten LJ
    Eur Urol; 2008 Jun; 53(6):1193. PubMed ID: 17709172
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial comment.
    Epstein JI
    J Urol; 2010 Mar; 183(3):1001. PubMed ID: 20089268
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment.
    Vollmer RT
    J Urol; 2010 Mar; 183(3):1001-2. PubMed ID: 20089267
    [No Abstract]   [Full Text] [Related]  

  • 14. Transrectal prostate biopsy.
    Ismail MT; Gomella LG
    Urol Clin North Am; 2013 Nov; 40(4):457-72. PubMed ID: 24182969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial Comment to Magnetic resonance spectroscopy imaging-directed transrectal ultrasound biopsy increases prostate cancer detection in men with prostate-specific antigen between 4-10 ng/mL and normal digital rectal examination.
    Goris Gbenou MC
    Int J Urol; 2014 Mar; 21(3):262-3. PubMed ID: 24015755
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: Post-treatment prostate biopsies in the era of three-dimensional conformal radiotherapy: what can they teach us?
    Stanislaus P; Seitz M
    Eur Urol; 2009 Apr; 55(4):909-10. PubMed ID: 18485577
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial Comment.
    Schroeck FR; Sirovich BE
    Urology; 2015 Dec; 86(6):1198-9. PubMed ID: 26719119
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment on: Measurement of serum isoform [-2]proPSA derivatives shows superior accuracy to magnetic resonance imaging in the diagnosis of prostate cancer in patients with a total prostate-specific antigen level of 2-10 ng/ml.
    Abrate A; Simonato A
    Scand J Urol; 2017 Aug; 51(4):258-259. PubMed ID: 28398109
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial Comment.
    Hoimes CJ; Madabhushi A
    Urology; 2016 Feb; 88():132-3. PubMed ID: 26964790
    [No Abstract]   [Full Text] [Related]  

  • 20. Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen.
    Hambrock T; Somford DM; Hoeks C; Bouwense SA; Huisman H; Yakar D; van Oort IM; Witjes JA; Fütterer JJ; Barentsz JO
    J Urol; 2010 Feb; 183(2):520-7. PubMed ID: 20006859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.